US Bancorp
GOSS icon

US Bancorp’s Gossamer Bio GOSS Stock Holding History

US Bancorp’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-301
Closed -$29.6K – 4126
2025
Q2 		$29.6K Sell
301
-118
-28% -$10.3K ﹤0.01% 3019
2025
Q1 		$36.8K Sell
419
-77
-16% -$7.12K ﹤0.01% 2891
2024
Q4 		$35.9K Hold
496
– – ﹤0.01% 2907
2024
Q3 		$39.1K Buy
+496
New +$38.2K ﹤0.01% 2858
2023
Q1 		– Sell
-8
Closed -$1.3K – 4140
2022
Q4 		$1.3K Sell
8
-1
-11% -$659 ﹤0.01% 3880
2022
Q3 		$8K Buy
+9
New +$8.94K ﹤0.01% 3444
2022
Q1 		– Sell
-19
Closed -$17K – 4112
2021
Q4 		$17K Hold
19
– – ﹤0.01% 3201
2021
Q3 		$19K Sell
19
-3
-14% -$2.21K ﹤0.01% 3155
2021
Q2 		$14K Buy
22
+2
+10% +$1.39K ﹤0.01% 3288
2021
Q1 		$15K Sell
20
-2
-9% -$1.61K ﹤0.01% 3144
2020
Q4 		$17K Buy
22
+11
+100% +$8.67K ﹤0.01% 2978
2020
Q3 		$11K Sell
11
-1
-8% -$1.06K ﹤0.01% 3046
2020
Q2 		$13K Buy
12
+3
+33% +$3.02K ﹤0.01% 3005
2020
Q1 		$8K Hold
9
– – ﹤0.01% 3092
2019
Q4 		$12K Buy
9
+6
+200% +$9.67K ﹤0.01% 3042
2019
Q3 		$4K Buy
+3
New +$4.77K ﹤0.01% 3281

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

US Bancorp's GOSS Position: Q3 2025 in Review

US Bancorp sold out of Gossamer Bio (GOSS) in Q3 2025, closing a stake of 301 shares — an estimated $29.6K sold.

US Bancorp first reported a position in GOSS in Q3 2019 and held it in 16 quarters. The position peaked at $39.1K in Q3 2024. 162 funds tracked by Wall St. Rank hold GOSS as of Q3 2025.

  • US Bancorp reported no remaining Gossamer Bio position as of Q3 2025 after selling out during the quarter.
  • US Bancorp sold 301 Gossamer Bio shares in Q3 2025, an estimated $29.6K.
  • US Bancorp first reported a position in Gossamer Bio in Q3 2019 and held it in 16 quarters.
  • US Bancorp's Gossamer Bio position peaked at $39.1K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2025.

Based on US Bancorp's 13F filing for Q3 2025, filed 12 Nov 2025.